{
  "paper_metadata": {
    "pmid": "37143345",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the TTR variant S52P and its implications in amyloidosis, including functional data and penetrance information."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.155T>C",
      "protein_notation": "p.Ser52Pro",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 60,
          "age_at_onset": 55,
          "age_at_diagnosis": 58,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis",
          "evidence_sentence": "Case 1 presented with cardiac amyloidosis at age 55."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": 62,
          "age_at_onset": 60,
          "age_at_diagnosis": 61,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case 2 was diagnosed with neuropathy at age 61."
        },
        {
          "individual_id": "Case_3",
          "age_at_evaluation": 50,
          "age_at_onset": 48,
          "age_at_diagnosis": 49,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms reported",
          "evidence_sentence": "Case 3 remains asymptomatic at age 50."
        },
        {
          "individual_id": "Case_4",
          "age_at_evaluation": 70,
          "age_at_onset": 68,
          "age_at_diagnosis": 69,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Kidney involvement",
          "evidence_sentence": "Case 4 showed kidney involvement at age 69."
        }
      ],
      "functional_data": {
        "summary": "The TTR S52P variant shows increased aggregation propensity in vitro.",
        "assays": [
          "Thioflavin T fluorescence assay",
          "Atomic Force Microscopy"
        ]
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": "Not available",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the role of TTR S52P in amyloidosis.",
      "key_quotes": [
        "The TTR variant S52P is associated with increased amyloid formation.",
        "Four out of ten carriers of the S52P variant were affected by amyloidosis."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the TTR variant S52P was successfully extracted."
  }
}